基于IgA脏病发病的向治疗选择
Susu Bo1, Ao Sun1, Weiguang Yang1
1Department of Nephrology, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.
概括
抗体A病 (IgAN) 是造成病的主要原因. 最近的进展提供了针对IgAN复杂机制的新疗法,并改善了患者的治疗结果.
科学领域:
- 肝脏病学
- 免疫学
- 病理学
背景情况:
- 在全球范围内,IgA病 (IgAN) 是导致慢性病和功能衰竭的首要原因.
- 它的复杂病原包括IgA免疫复合体沉积,导致质硬化和纤维化.
- 目前只有有限的特定治疗方法,目前的治疗重点是支持性治疗和RAAS阻断.
研究的目的:
- 审查 IgA 病治疗策略的最新进展.
- 突出Igan的新兴治疗目标和方法.
- 讨论Igan药物开发和临床试验的不断变化.
主要方法:
- 最近IgAN研究和临床试验的文献综述.
- 基于IgAN病变的分子机制的分析.
- 对针对IgAN的新疗法进行评估.
主要成果:
- 新兴药物试验提供了除了支持性护理之外的新疗法.
- 新的策略旨在抑制炎症,向纤维化,并减少致病性IgA的产生.
- 了解IgAN的发病性正在加速药物批准过程.
结论:
- 在开发向IgAN疗法方面取得了显著进展.
- 一种多方治疗方法正在出现,以解决IgAN的后果和机制.
- 未来的研究有望改善IgAN管理和患者的预后.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Open Angle Glaucoma: Treatment
561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
Antihypertensive Drugs: Direct Renin Inhibitors
819
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
819


